Filing Details
- Accession Number:
- 0001209191-17-003452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-11 21:21:12
- Reporting Period:
- 2017-01-09
- Filing Date:
- 2017-01-11
- Accepted Time:
- 2017-01-11 21:21:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1601949 | Paul Westberg | C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025 | Sr. Vp, Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-01-09 | 2,312 | $1.27 | 46,912 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2017-01-09 | 11,044 | $1.38 | 57,956 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-01-09 | 13,356 | $15.93 | 44,600 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-01-10 | 10,467 | $1.38 | 55,067 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2017-01-10 | 746 | $1.61 | 55,813 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-01-10 | 11,213 | $15.66 | 44,600 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-01-11 | 7,931 | $1.61 | 52,531 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-01-11 | 7,931 | $15.24 | 44,600 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-09 | 2,312 | $0.00 | 2,312 | $1.27 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-09 | 11,044 | $0.00 | 11,044 | $1.38 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-10 | 10,467 | $0.00 | 10,467 | $1.38 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-10 | 746 | $0.00 | 746 | $1.61 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-01-11 | 7,931 | $0.00 | 7,931 | $1.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-03-29 | No | 4 | M | Direct | |
10,467 | 2022-04-30 | No | 4 | M | Direct | |
0 | 2022-04-30 | No | 4 | M | Direct | |
23,524 | 2023-01-22 | No | 4 | M | Direct | |
15,593 | 2023-01-22 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 trading plan.
- The shares were sold at prices ranging from $15.75 to $16.35. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $15.50 to $15.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $15.00 to $15.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
- Twenty-Five percent of the shares subject to the option become exercisable one year from 1/23/2013; the remainder become exercisable in equal monthly installments over the following three years.